Director/PDMR Shareholding

Further to the announcement made on 8 October 2018, MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that Andrew Barker, Non-Executive Director of the Company, has been issued 66,781 new ordinary shares of 1 pence each in the capital of the Company (“Ordinary Shares”) pursuant to the completion of the acquisition of Intelligent Ultrasound Limited, which was originally announced on 19 September 2017. Following this issue, Mr. Barker has an interest in 200,344 Ordinary Shares representing approximately 0.2 per cent. of the Company's issued ordinary share capital. Full announcement is available here. Enquiries: investors.medaphor.com/advisors 

October 9th, 2018|

Payment of deferred consideration

On 6 October 2017, MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announced completion of the acquisition of Intelligent Ultrasound Limited ("IUL") (the “Acquisition”) pursuant to a sale and purchase agreement (the “IUL SPA”).  In accordance with the terms of the IUL SPA, 6,175,975 new ordinary shares of 1p each in the Company (“Ordinary Shares”) (“the Retention Shares”) and a new warrant certificate representing rights to subscribe for 418,897 new Ordinary Shares (“the Retention Warrants”) are being issued to the vendors of IUL (“Vendors”). The issue of the Retention Shares and the Retention Warrants was, under the [...]

October 8th, 2018|